PLUS1
Kazia Therapeutics Financial Data
| Company name: | Kazia Therapeutics Ltd | Status: | Active |
| End of fiscal year: | 2018年6月30日 | ISIN | AU000000KZA9 |
| Auditor: | Grant Thornton Audit Pty Ltd | Year established: | 1994 |
| Company sector name: | Healthcare | Trading currency: | AUD |
| Industry name: | Biotechnology | Place of incorporation: | Australia (AU) |
| Industry group name | Biotechnology | Doing business in: | Australia (AU) |
| Address | 300 Barangaroo Avenue Level 24, 2000 | Tel.: | +61 294724101 |
| City/Country: | Sydney, Australia | Fax: | +61 294760388 |
| Web address: | http://www.novogen.com |
| Company description: | Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing innovative anti-cancer drugs. The company has three technologies - PI3K inhibitors, superbenzopyran, and anti-tropomyosin. The group is developing GDC-0084, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; Trilexium, has a potential application across a range of different cancer types. |
| 現在 | 前日比 [%] | ビッド | オファー | 始値 | 高値 | 安値 | 数量 |
|---|---|---|---|---|---|---|---|
| 0.615 | 0.00[0.0%] | 0.595 | 0.63 | 0.00 | |||
| 時価総額 [百万] | 発行済株式数 [百万] | Beta | EPS | DPS | PER | 利回り | 52週レンジ |
| 29.751562875 | 48.409621 | -0.03 | -0.12 | - | -4.93 | - | 0.59 - 1.65 |
KZA KEY FIGURES (at previous day's close) | |
|---|---|
Yesterday's Close | 0.62 |
PE Ratio | -4.93 |
Market Capitalisation | 29.75M |
Latest Shares Outstanding | 48.41M |
Earnings pS (EPS) | -0.12 |
Dividend pS (DPS) | - |
Dividend Yield | - |
Sales per Employee | - |
Effective Tax Rate | - |
Foreign Sales | - |
Domestic Sales | - |
Selling, General & Adm/tive (SG... | - |
Research & Devlopment (R&D) as ... | - |
Gross Profit Margin | - |
EBITDA Margin | - |
Pre-Tax Profit Margin | - |
Assets Turnover | - |
Return on Assets (ROA) | -0.19% |
Return on Equity (ROE) | -0.27% |
Return on Capital Invested (ROC... | -0.28% |
Current Ratio | 2.38 |
Leverage Ratio (Assets/Equity) | 1.46% |
Interest Cover | - |
Total Debt/Equity (Gearing Rati... | - |
LT Debt/Total Capital | - |
Working Capital pS | 0.50 |
Cash pS | 0.12 |
Book-Value pS | 0.28 |
Tangible Book-Value pS | 0.09 |
Cash Flow pS | -0.18 |
Free Cash Flow pS | -0.18 |
Spread | 0.04 |
Gross gearing | 0.00% |
Net Debt | -5.96M |
KZA Balance Sheet Chart (2018年6月30日) | ||
|---|---|---|
 | ||
| 期間 † | 高値 | 安値 |
|---|---|---|
| 1週 | 0.68 | 0.585 |
| 1ヶ月 | 0.835 | 0.585 |
| 3ヶ月 | 1.14 | 0.585 |
| 6ヶ月 | 1.31 | 0.585 |
| 1年 | 1.65 | 0.585 |
| 3年 | 1.88 | 0.34 |
| 5年 | 1.88 | 0.32 |
Share price performance previous 3 years |
|---|
Share price performance intraday |
|---|
| 期間 † | 始値 | 平均始値 | VWAP | 最小出来高 | 最大出来高 | 平均出来高 | 前日比 | % |
|---|---|---|---|---|---|---|---|---|
| 1週 | 0.675 | 0.627 | 0.622179 | 31,233 | 231,999 | 96,266 | -0.06 | -8.89% |
| 1ヶ月 | 0.79 | 0.725921 | 0.709964 | 12,448 | 413,668 | 97,899 | -0.175 | -22.15% |
| 3ヶ月 | 1.08 | 0.827773 | 0.786861 | 2,293 | 441,196 | 97,465 | -0.465 | -43.06% |
| 6ヶ月 | 1.16 | 0.933455 | 0.895976 | 1,033 | 441,196 | 76,302 | -0.545 | -46.98% |
| 1年 | 1.305 | 1.1556 | 1.09 | 1,033 | 451,151 | 66,393 | -0.69 | -52.87% |
| 3年 | 0.355 | 0.934979 | 0.990099 | 100 | 7,464,227 | 162,578 | 0.26 | 73.24% |
| 5年 | 0.40 | 0.80562 | 0.93976 | 89 | 7,464,227 | 127,957 | 0.215 | 53.75% |
KZA Growth Ratios (2018年6月30日) | ||||
|---|---|---|---|---|
| 1 year | 3 years | 5 years | 10 years | |
Diluted EPS growth | - | - | - | - |
Diluted continuous EPS growth | - | - | - | - |
Dividend growth | - | - | - | - |
Equity per share growth | -0.24 | -0.28 | 0.07 | -0.19 |
Revenue growth | - | 0.00 | - | - |
Operating income growth | - | - | - | - |
Net income growth | - | - | - | - |
Net income cont growth | - | - | - | - |
CFO growth | - | - | - | - |
FCF growth | - | - | - | - |
Operating revenue growth | - | 0.00 | - | - |
KZA Income Statement 2018年6月30日 (AUD) | |
|---|---|
Total Revenue | 0.00 |
Operating Revenue | 0.00 |
Operating Expenses | 12.487 |
Selling,General and Administr... | 5.598 |
General and Administrative Ex... | 5.598 |
OtherGandA | 5.598 |
Research and Development | 7.574 |
Other Operating Expenses | -0.685 |
Operating Income | -12.487 |
Interest Income/Expense,Net-N... | 0.119 |
Interest Income-Non Operating | 0.119 |
Other Income/Expense,Net | 6.023 |
Gain on Sale of Securities | -0.89 |
Special Income/Charges | 5.444 |
Write Off | 2.83 |
Other Special Charges | -8.411 |
Gain on Sale of Business | 0.00 |
Gain on Sale of Property,Plan... | -0.137 |
Other Non-Operating Income/Ex... | 1.469 |
Pretax Income | -6.344 |
Provision for Income Tax | -0.305 |
Net Income Available to Commo... | -6.039 |
Net Income | -6.039 |
Net Income Including Noncontr... | -6.039 |
Net Income from Continuing Op... | -6.039 |
Minority Interest | 0.00 |
DilutedNIAvailtoComStockholde... | -6.039 |
Basic EPS | -0.12 |
Basic EPS from Continuing Ope... | -0.12 |
Diluted EPS | -0.12 |
Diluted EPS from Continuing O... | -0.12 |
Basic Weighted Average Shares... | 48.376525 |
Diluted Weighted Average Shar... | 48.376525 |
Total Expenses | 12.487 |
Net Income from Continuing an... | -6.039 |
Normalized Income | -10.3740576923 |
Basic EPS,Continuing and Disc... | -0.12 |
Diluted EPS,Continuing and Di... | -0.12 |
Interest and Dividend Income | 0.119 |
Net Interest Income | 0.119 |
Earning Before Interest and T... | -12.487 |
Earning Before Interest Tax D... | -10.94 |
Depreciation,Reconciled | 1.547 |
Net Income from Continuing Op... | -6.039 |
TotalUnusualItemsExcludingGoo... | 4.554 |
TotalUnusualItems | 4.554 |
Normalized Basic EPS | -0.21 |
Normalized Diluted EPS | -0.21 |
NormalizedEBITDA | -15.494 |
Tax rate for calculations | 0.05 |
KZA Efficency Ratios (2018年6月30日) | |
|---|---|
Days in sales | - |
Days in inventory | - |
Days in payment | - |
Cash conversion cycle | - |
Receivable turnover | - |
Inventory turnover | - |
Payable turnover | - |
Fixed assets turnover | - |
Assets turnover | - |
ROE | -0.27 |
ROA | -0.19 |
ROIC | -0.28 |
FCF sales ratio | - |
FCF net income ratio | - |
Capital expenditure sales ratio | - |
KZA Financial Health Ratios (2018年6月30日) | |
|---|---|
Current ratio | 2.38 |
Quick ratio | 2.18 |
Debt total capital ratio | - |
Debt equity ratio | - |
Financial leverage | 1.46 |
Total debt to equity | - |
KZA Avearge Growth Ratios Over 5 Years (2018年6月30日) | |
|---|---|
Growth ann capital spending | - |
Growth ann gross profit | - |
Avg gross margin | - |
Avg post tax margin | - |
Avg pre tax marginr | - |
Avg net profit | - |
Avg ret commonr | -0.79 |
Avg ret assets | -0.50 |
Avg ret invested capital | -0.54 |
KZA Profitability Ratios (2018年6月30日) | |
|---|---|
Gross margin | - |
Operating margin | - |
EBT margin | - |
Tax rate | - |
Net margin | - |
Sales per employee | - |
EBIT margin | - |
EBITDA margin | - |
Normalized net profit margin | - |
Interest coverage | - |
Inc per employee tot ops | - |
KZA Valuation Ratios (2018年6月29日) | |
|---|---|
Sales per share | - |
Growth ann sales per share 5 ye... | - |
Book value per share | 0.53 |
CF per share | -0.24 |
Price to EPS | - |
Ratio PE 5 year high | - |
Ratio PE 5 year low | - |
Price to book | 0.80 |
Price to sales | - |
Price to cash flow | - |
Price to free cash flow | - |
Div rate | - |
Dividend yield | - |
Div payout tot ops | - |
Div payout 5 year | - |
Payout ratio | 0.00 |
Sustainable growth rate | -0.21 |
Cash return | -0.79 |
KZA Balance Sheet 2018年6月30日 (AUD) | |
|---|---|
Total Assets | 28.175 |
Current Assets | 9.26 |
Cash,Cash Equivalents,and Sho... | 5.956 |
Cash and Cash Equivalents | 5.956 |
Cash | 2.956 |
Cash Equivalents | 3 |
Receivables | 2.536 |
Accounts Receivable | 1,000.00 |
Accounts Receivable,Gross | 1,000.00 |
Taxes Receivable | 2.2 |
Other Receivables | 0.729 |
Recievables Adjustments/Allow... | -0.394 |
Prepaid Assets and Others | 0.768 |
Total Non-Current Assets | 18.915 |
Net Property,Plant,and Equipm... | 1,000.00 |
Gross Property,Plant,and Equi... | 2,000.00 |
Properties | 0.00 |
Machinery,Furniture/Equipment | 2,000.00 |
Leasehold and Improvements | 0.00 |
Accumulated Depreciation | -1,000.00 |
Goodwill and Other Intangible... | 14.579 |
Other Intangible Assets | 14.579 |
Investments and Advances | 3.68 |
Investment in Financial Asset... | 3.68 |
Available-for-Sale Securities | 3.68 |
Derivative Assets,Non-Current | 0.655 |
Total Liabilities | 8.933 |
Current Liabilities | 3.887 |
Payables and Accrued Expenses | 2.067 |
Payables | 2.067 |
Accounts Payable | 1.407 |
Other Payable | 0.66 |
Provisions,Current | 0.161 |
Deferred Liabilities,Current | 0.138 |
Deferred Revenue,Current | 0.138 |
Other Current Liabilities | 1.521 |
Total Non-Current Liabilities | 5.046 |
Deferred Liabilities, Non cur... | 4.009 |
Deferred Taxes,Non-Current Li... | 4.009 |
Trade and Other Payables, Non... | 0.00 |
Other Non-Current Liabilities | 1.037 |
Total Equity | 19.242 |
Stockholder's Equity | 19.242 |
Capital Stock | 0.00 |
Common Stock | 0.00 |
Additional Paid in Capital | 31.576 |
Retained Earnings | -14.641 |
Accumulated Gains/ Losses Not... | 1.843 |
Other Equity Interest | 0.464 |
Total Capitalization | 19.242 |
Common Stock Equity | 19.242 |
Net Tangible Assets | 4.663 |
Working Capital | 5.373 |
Invested Capital | 19.242 |
Tangible Book Value | 4.663 |
Ordinary Shares Number | 48.409621 |
TotalLiabilitiesAsReported | 8.933 |
TotalEquityAsReported | 19.242 |
KZA Cash Flow 2018年6月30日 (AUD) | |
|---|---|
Cash Flow from Operating Acti... | -8.661 |
Cash Flow from Continuing Ope... | -8.66 |
Net Income from Continuing Op... | -6.039 |
Operating Gains/Losses | -0.114 |
Gain/Loss on Sale of Business | 0.00 |
Net Foreign Currency Exchange... | -0.251 |
Depreciation,Amortization and... | 1.547 |
Depreciation and Amortization | 1.547 |
Asset Impairment Charge | 2.973 |
Unrealized Gain/Loss on Inves... | 1.114 |
Stock-Based Compensation | 0.165 |
Other Non-Cash Items | -9.843 |
Changes in Working Capital | 1.536 |
Change in Receivables | 1.821 |
Changes in Account Receivable... | 1.724 |
Change in Prepaid Assets | -10,000.00 |
Change in Payables and Accrue... | 0.088 |
Change in Payables | 0.088 |
Change in Other Working Capit... | -0.363 |
Cash Flow from Investing Acti... | 0.15 |
Cash Flow from Continuing Inv... | 0.15 |
Purchase/Sale of Property,Pla... | 0.00 |
Purchase of Property,Plant an... | 0.00 |
Sale of Property,Plant,and Eq... | 0.00 |
Purchase/Sale of Intangibles,... | 0.00 |
Purchase of Intangibles | 0.00 |
Purchase/Sale of Business,Net | 0.00 |
Sale of Business | 0.00 |
Other Investing Changes,Net | 0.15 |
Cash Flow from Financing Acti... | 0.00 |
Cash Flow from Continuing Fin... | 0.00 |
Proceeds or Issuance of Commo... | 0.00 |
Cash and Cash Equivalents,End... | 5.956 |
Change in Cash | -8.511 |
Effect of Exchange Rate Chang... | 0.012 |
Cash and Cash Equivalents,Beg... | 14.455 |
Issuance of Capital Stock | 0.00 |
Free Cash Flow | -8.661 |
ChangeinCashSupplementalAsRep... | -8.511 |
